162 related articles for article (PubMed ID: 38306570)
1. BZW1 is a prognostic and immunological biomarker in pancreatic adenocarcinoma.
Luo A; Qiao N; Hu K; Xu H; Xie M; Jiang Y; Hu J
Medicine (Baltimore); 2024 Feb; 103(5):e37092. PubMed ID: 38306570
[TBL] [Abstract][Full Text] [Related]
2. BZW1 Facilitates Glycolysis and Promotes Tumor Growth in Pancreatic Ductal Adenocarcinoma Through Potentiating eIF2α Phosphorylation.
Li Z; Ge Y; Dong J; Wang H; Zhao T; Wang X; Liu J; Gao S; Shi L; Yang S; Huang C; Hao J
Gastroenterology; 2022 Apr; 162(4):1256-1271.e14. PubMed ID: 34951995
[TBL] [Abstract][Full Text] [Related]
3. Expression, oncological and immunological characterizations of BZW1/2 in pancreatic adenocarcinoma.
Ge J; Mu S; Xiao E; Tian G; Tao L; Li D
Front Genet; 2022; 13():1002673. PubMed ID: 36267402
[No Abstract] [Full Text] [Related]
4. [Pan-cancer analysis of ubiquitin-specific protease 7 and its expression changes in the carcinogenesis of scar ulcer].
Zhang SY; Ruan JJ; Jin DM; Chen N; Xie WG; Ruan QF
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 Jun; 39(6):518-526. PubMed ID: 37805766
[No Abstract] [Full Text] [Related]
5. BZW1 promotes cell proliferation in prostate cancer by regulating TGF-β1/Smad pathway.
Shi Z; Xiao C; Lin T; Wu J; Li K
Cell Cycle; 2021 May; 20(9):894-902. PubMed ID: 33886419
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of BZW1 is an independent poor prognosis marker and its down-regulation suppresses lung adenocarcinoma metastasis.
Chiou J; Chang YC; Jan YH; Tsai HF; Yang CJ; Huang MS; Yu YL; Hsiao M
Sci Rep; 2019 Oct; 9(1):14624. PubMed ID: 31601833
[TBL] [Abstract][Full Text] [Related]
7. Cuproptosis-related lncRNA scoring system to predict the clinical outcome and immune landscape in pancreatic adenocarcinoma.
Huang Y; Gong P; Su L; Zhang M
Sci Rep; 2023 Nov; 13(1):20870. PubMed ID: 38012210
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value and the Immune Microenvironment-associated Role of
Song Y; Wang Y; Yu T; He Y; Wang C; Wang F; Zhou Y
Anticancer Res; 2023 Dec; 43(12):5393-5408. PubMed ID: 38030175
[TBL] [Abstract][Full Text] [Related]
10. Translational autoregulation of BZW1 and BZW2 expression by modulating the stringency of start codon selection.
Loughran G; Firth AE; Atkins JF; Ivanov IP
PLoS One; 2018; 13(2):e0192648. PubMed ID: 29470543
[TBL] [Abstract][Full Text] [Related]
11. Systematic investigation of the clinical significance and prognostic value of the CBXs in esophageal cancer.
Hou J; Yang Y; Gao H; Ouyang T; Liu Q; Ding R; Kan H
Medicine (Baltimore); 2022 Oct; 101(40):e30888. PubMed ID: 36221371
[TBL] [Abstract][Full Text] [Related]
12. Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tumor immune microenvironment of pancreatic adenocarcinoma.
Wang L; Zhang S; Li H; Xu Y; Wu Q; Shen J; Li T; Xu Y
BMC Cancer; 2021 Jul; 21(1):876. PubMed ID: 34332578
[TBL] [Abstract][Full Text] [Related]
13. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
[TBL] [Abstract][Full Text] [Related]
14. Identification of Key Prognostic Biomarker and Its Correlation with Immune Infiltrates in Pancreatic Ductal Adenocarcinoma.
Luan H; Zhang C; Zhang T; He Y; Su Y; Zhou L
Dis Markers; 2020; 2020():8825997. PubMed ID: 32934754
[TBL] [Abstract][Full Text] [Related]
15. Long non‑coding RNA NEAT1 modifies cell proliferation, colony formation, apoptosis, migration and invasion via the miR‑4500/BZW1 axis in ovarian cancer.
Xu H; Sun X; Huang Y; Si Q; Li M
Mol Med Rep; 2020 Oct; 22(4):3347-3357. PubMed ID: 32945505
[TBL] [Abstract][Full Text] [Related]
16. BZW1 as an oncogene is associated with patient prognosis and the immune microenvironment in glioma.
Zhao L; Song C; Li Y; Yuan F; Zhao Q; Dong H; Liu B
Genomics; 2023 May; 115(3):110602. PubMed ID: 36907429
[TBL] [Abstract][Full Text] [Related]
17. Identify potential prognostic indicators and tumor-infiltrating immune cells in pancreatic adenocarcinoma.
Shi T; Gao G
Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35083488
[TBL] [Abstract][Full Text] [Related]
18. A Four Autophagy-Related Gene-Based Prognostic Signature for Pancreatic Cancer.
Zhou Q; Chen X; Chen Q; Liu H; Hao L
Crit Rev Eukaryot Gene Expr; 2021; 31(4):89-100. PubMed ID: 34587439
[TBL] [Abstract][Full Text] [Related]
19. BZW1, a novel proliferation regulator that promotes growth of salivary muocepodermoid carcinoma.
Li S; Chai Z; Li Y; Liu D; Bai Z; Li Y; Li Y; Situ Z
Cancer Lett; 2009 Oct; 284(1):86-94. PubMed ID: 19446954
[TBL] [Abstract][Full Text] [Related]
20. A novel immune checkpoint score system for prognostic evaluation in pancreatic adenocarcinoma.
Chen Y; Lin X; Zou X; Qian Y; Liu Y; Wang R; Wang X; Yu X; Liu C; Cheng H
BMC Gastroenterol; 2023 Apr; 23(1):113. PubMed ID: 37024802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
